Contribution of insulin-like growth factor (IGF)-I and IGF-binding protein-3 to mitogenic activity in bovine mammary extracts and serum.
Peripubertal development of the mammary gland is probably mediated by locally produced growth factors acting in concert with circulating mitogens. Our objective was to investigate the effect of recombinant human insulin-like growth factor-binding protein-3 (rhIGFBP-3) or insulin-like growth factor-I (IGF-I) antibodies on the IGF-I-related mitogenic activity of bovine serum and of mammary tissue extracts in primary mammary epithelial cell cultures. Cells were obtained from prepubertal female calf mammary tissue and cultured in three-dimensional collagen gels. An aqueous mammary parenchymal tissue extract (pooled from 20 prepubertal heifers) or serum (pooled from 3 heifers) at a concentration of 5% was added to the medium containing either rhIGFBP-3 or monoclonal or polyclonal antibodies to human IGF-I. Cell proliferation was evaluated using [methyl-3H]thymidine incorporation as a measure of DNA synthesis. Addition of mammary extracts stimulated DNA synthesis 545% compared with basal medium. Addition of serum stimulated DNA synthesis by 28%. Mitogenic activity of serum and added IGF-I was abolished by addition of rhIGFBP-3 in equimolar concentrations with IGF-I. For mammary extracts, mitogenic activity was inhibited by 35%, 50%, and 82% by the addition of rhIGFBP-3 at, respectively, 1, 2 and 4 times the molar IGF-I concentration in the extract. Addition of rhIGFBP-3 to basal medium reduced DNA synthesis by 26%, whereas IGF-I antibodies had no consistent effect. These results indicate that circulating and mammary-synthesized IGF-I and IGFBPs probably play a critical role in prepubertal development of the bovine mammary gland.
Weber
M S
MS
Department of Dairy Science, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0315, USA.
Purup
S
S
Vestergaard
M
M
Ellis
S E
SE
Scndergård-Andersen
J
J
Akers
R M
RM
Sejrsen
K
K
D000704:Analysis of Variance; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D002417:Cattle; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004247:DNA / Q000096:biosynthesis; D004847:Epithelial Cells / Q000187:drug effects; D005260:Female; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000276:immunology / Q000494:pharmacology*; D007334:Insulin-Like Growth Factor I / Q000276:immunology / Q000494:pharmacology*; D016018:Least-Squares Analysis; D008321:Mammary Glands, Animal / Q000166:cytology* / Q000187:drug effects; D011485:Protein Binding; D011994:Recombinant Proteins / Q000494:pharmacology; D012741:Sexual Maturation / Q000502:physiology*; D014020:Tissue Extracts
D000911:Antibodies, Monoclonal; D018972:Insulin-Like Growth Factor Binding Protein 3; D011994:Recombinant Proteins; D014020:Tissue Extracts; D007334:Insulin-Like Growth Factor I; D004247:DNA